Skip to main content
logo
Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
India flag India · Delayed Price · Currency is INR
4,040.40
+53.20 (1.33%)
Feb 3, 2026, 2:21 PM IST

Torrent Pharmaceuticals Revenue

Torrent Pharmaceuticals had revenue of 33.02B INR in the quarter ending September 30, 2025, with 14.30% growth. This brings the company's revenue in the last twelve months to 122.48B, up 9.13% year-over-year. In the fiscal year ending March 31, 2025, Torrent Pharmaceuticals had annual revenue of 115.16B with 7.35% growth.

Revenue (ttm)
122.48B
Revenue Growth
+9.13%
P/S Ratio
11.03
Revenue / Employee
7.18M
Employees
17,059
Market Cap
1.35T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025115.16B7.88B7.35%
Mar 31, 2024107.28B11.08B11.51%
Mar 31, 202396.20B11.12B13.07%
Mar 31, 202285.08B5.03B6.29%
Mar 31, 202180.05B652.60M0.82%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries568.09B
Aurobindo Pharma325.14B
Cipla279.67B
Zydus Lifesciences244.94B
Glenmark Pharmaceuticals165.10B
Alkem Laboratories138.90B
Mankind Pharma135.46B
Divi's Laboratories100.29B
Revenue Rankings

Torrent Pharmaceuticals News

More News